Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at ranibizumab for eye cancer (NITRO)

Overview

Cancer types:

Melanoma

Status:

Results

Phase:

Phase 2

Details

This trial looked at a new drug called ranibizumab for a type of eye cancer called uveal melanoma.

Cancer Research UK supported this trial.

Recruitment start: 23 July 2012

Recruitment end: 17 October 2014

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof Heinrich Heimann

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Cancer Research Network: Cancer

Novartis

Royal Liverpool and Broadgreen University Hospital

The University of Liverpool Cancer Trials Unit

Other information

This is Cancer Research UK trial number CRUK/10/032.

Last reviewed: 09 Aug 2016

CRUK internal database number: 6187

Help and support